DVA240517C125000
- 12.05
- 0.000.00%
DaVita Newsroom
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
Merit Medical's (MMSI) Latest Launch to Boost Patient Care
Reasons to Add HealthEquity (HQY) Stock to Your Portfolio
DaVita (DVA) Gains 34.5% YTD: What's Driving the Stock?
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
McKesson (MCK) Hits 52-Week High: What's Driving the Stock?
Masimo's (MASI) New Offering to Serve Personalized Audio Market
Boston Scientific (BSX) Reaches 52-Week High: What's Aiding It?
Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers
Investors demanded more clarity from German healthcare group Fresenius SE regarding its intentions to relinquish strategic control over dialysis group Fresenius Medical Care AG (NYSE:FMS). The investo
Three Reasons to Retain AMN Healthcare (AMN) Stock for Now
Merit Medical (MMSI) to Expand Product Suite Via New Launch
DaVita Is Maintained at Hold by Truist Securities
DaVita Is Maintained at Hold by Truist Securities
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Denver, CO-headquartered DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD).
DaVita Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 9.38% Truist Securities $135 → $150 Maintains Hold 05/06/2024 9.38% Barclays $133 → $150 Mainta
Truist Financial Keeps Their Hold Rating on DaVita (DVA)
Express News | DaVita Inc : Truist Securities Raises Target Price to $150 From $135
Truist Securities Raises Price Target on DaVita to $150 From $135, Keeps Hold Rating
DaVita (DVA) has an average rating of hold and price targets ranging from $122 to $169, according to analysts polled by Capital IQ. Price: 134.74, Change: -2.27, Percent Change: -1.66
DaVita: A Cautious Outlook Amid Growth Uncertainty and Inflation Challenges
DaVita(DVA.US) Director Sells US$698.21K in Common Stock
$DaVita(DVA.US)$ Director DESOER BARBARA J sold 5,030 shares of common stock on May 10, 2024 at an average price of $138.81 for a total value of $698.21K.Source: Announcement What is statement of chan
Davita Insider Sold Shares Worth $698,214, According to a Recent SEC Filing
Barbara J Desoer, Director, on May 10, 2024, sold 5,030 shares in Davita (DVA) for $698,214. Following the Form 4 filing with the SEC, Desoer has control over a total of 10,954 shares of the company,